the most common were dry mouth and insomnia. Astrup et al., The Lancet Who Should Avoid Tesofensine Individuals with uncontrolled hypertension or cardiovascular disease Anyone on SSRIs, SNRIs, or MAO inhibitors (risk of serotonin syndrome) Those with a history of severe anxiety, panic disorder, or arrhythmias Pregnant or breastfeeding women (due to lack of safety data) Best Practices for Safety Start at 0.25 mg/day and gradually titrate Avoid stacking with caffeine , yohimbine , or stim-heavy pre-workouts Monitor blood pressure, heart rate, and sleep quality Discontinue use if side effects worsen or persist beyond the adaptation period (710 days) Although Tesofensine has a relatively clean side effect profile at moderate doses, its still a powerful central agent
She has taken a ton of time with both of us when it comes to reviewing results and explaining treatments and protocols
BPC-157 and TB-500 have zero published human RCTs as of mid-2026
Im on my fifth shot and Im feeling great
The medication has successfully passed phase I and II clinical trials and is currently in phase III clinical trials
Mass spectrometry, HPLC, and other analytical techniques can quantify intact peptide remaining after storage